Literature DB >> 18985405

[Validation of secondary data. Strengths and limitations].

F Hoffmann1, F Andersohn, K Giersiepen, E Scharnetzky, E Garbe.   

Abstract

Medical records databases (such as the General Practice Research Database-GPRD) and administrative databases (such as German Statutory Health Insurance (SHI) claims data) are useful sources for pharmacoepidemiology and health services research. However, these data are not primarily collected for research purposes. Validation studies are needed to examine their completeness and accuracy depending on the corresponding research question. This article reviews strategies for checks of internal consistency within the data from one SHI as well as between data from several SHIs and possibilities of internal data validation. Descriptive analyses of consistency can help to determine the integrity of data. The aim of internal validation is to separate uncertain from true cases based on information from secondary data alone or to reproduce known associations within the database. In addition external validation of secondary data is desirable using original prescriptions, medical records, hospital discharge letters and/or patient or physician interviews as a gold standard. A considerable number of external validation studies of diagnostic coding have been conducted within the GPRD. In contrast, such validation studies of German SHI claims data are mostly lacking and are urgently needed in the near future.

Entities:  

Mesh:

Year:  2008        PMID: 18985405     DOI: 10.1007/s00103-008-0646-y

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  12 in total

1.  [Health services research in oncology using claims data].

Authors:  Falk Hoffmann; Gerd Glaeske
Journal:  Med Klin (Munich)       Date:  2010-06-26

2.  [Limits in health services research].

Authors:  C Röllig
Journal:  Urologe A       Date:  2011-06       Impact factor: 0.639

3.  Pregnancy rates and perinatal outcomes in women with systemic lupus erythematosus: data from the Korean national health claims database.

Authors:  Young Bin Joo; Ki-Jo Kim; Kyung-Su Park; Yune-Jung Park
Journal:  Clin Rheumatol       Date:  2020-11-12       Impact factor: 2.980

Review 4.  [Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version].

Authors:  J Callhoff; K Albrecht; F Hoffmann; D Poddubnyy; K-P Günther; A Zink
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

5.  [Prevalence of rheumatoid arthritis in Germany based on health insurance data : Regional differences and first results of the PROCLAIR study].

Authors:  S Hense; A Luque Ramos; J Callhoff; K Albrecht; A Zink; F Hoffmann
Journal:  Z Rheumatol       Date:  2016-10       Impact factor: 1.372

6.  Differences in the Incidence of Gestational Diabetes between Women of Turkish and German Origin: An Analysis of Health Insurance Data From a Statutory Health Insurance in Berlin, Germany (AOK), 2005-2007.

Authors:  A Reeske; H Zeeb; O Razum; J Spallek
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-04       Impact factor: 2.915

7.  Prevalence of diagnosis and direct treatment costs of back disorders in 644,773 children and youths in Germany.

Authors:  Elke B Ochsmann; Carlos L Escobar Pinzón; Stephan Letzel; Thomas Kraus; Martina Michaelis; Eva Muenster
Journal:  BMC Musculoskelet Disord       Date:  2010-08-28       Impact factor: 2.362

8.  Regional and temporal variations in coding of hospital diagnoses referring to upper gastrointestinal and oesophageal bleeding in Germany.

Authors:  Ingo Langner; Rafael Mikolajczyk; Edeltraut Garbe
Journal:  BMC Health Serv Res       Date:  2011-08-17       Impact factor: 2.655

9.  Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation study.

Authors:  Christoph Ohlmeier; Ingo Langner; Kathrin Hillebrand; Niklas Schmedt; Rafael Mikolajczyk; Oliver Riedel; Edeltraut Garbe
Journal:  BMC Public Health       Date:  2015-06-20       Impact factor: 3.295

10.  Sex Disparities in Long-Term Mortality after Paclitaxel Exposure in Patients with Peripheral Artery Disease: A Nationwide Claims-Based Cohort Study.

Authors:  Christian-Alexander Behrendt; Art Sedrakyan; Konstantinos Katsanos; Joakim Nordanstig; Jenny Kuchenbecker; Thea Kreutzburg; Eric A Secemsky; Eike Sebastian Debus; Ursula Marschall; Frederik Peters
Journal:  J Clin Med       Date:  2021-07-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.